| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/20/2005 | US20050014802 Prevent reproduction of virus; antitumor agents |
| 01/20/2005 | US20050014796 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/20/2005 | US20050014757 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 01/20/2005 | US20050014750 Isochroman compounds for treatment of cns disorders |
| 01/20/2005 | US20050014749 Piperazine derivatives and methods of use |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014700 Cbi analogues of cc-1065 and the duocarmycins |
| 01/20/2005 | US20050014650 Delta 1-pyrrolines used as pesticides |
| 01/20/2005 | DE102004014061A1 Amid-substituierte 1,2,4-Triazin-5(2H)-one Amide substituted 1,2,4-triazine-5 (2H) -ones |
| 01/20/2005 | CA2530737A1 Cck-1 receptor modulators |
| 01/20/2005 | CA2529739A1 Aspartyl protease inhibitors |
| 01/20/2005 | CA2528626A1 Indoles useful in the treatment of inflammation |
| 01/20/2005 | CA2526725A1 Mch antagonists for the treatment of obesity |
| 01/19/2005 | EP1498419A1 Process for preparing alkali metal salts of hydrophobic sulfonamides |
| 01/19/2005 | EP1498418A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 01/19/2005 | EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2005 | EP1497287A1 Quinolinone derivatives |
| 01/19/2005 | EP1497284A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 01/19/2005 | EP1497283A1 Maleic acid salt of(2s)-n-(5(amino(imino)methyl)-2-thienyl)methyl-1-(2r)-2-((2r)-2-((carboxymethyl)amino)3,3-diphenylpropanoyl)-2-pyrrolidine carboxamide and a process for |
| 01/19/2005 | EP1497278A1 Heterocyclic amide derivatives as cytokine inhibitors |
| 01/19/2005 | EP1497240A1 Non-heating clay composites for building materials |
| 01/19/2005 | EP1496906A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496896A1 Inhibitors of akt activity |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1395574B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 01/19/2005 | CN1568323A Activator for peroxisome proliferator-activated receptor delta |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566098A Isoquinoline compound, preparation method and application of salt thereof |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1566091A Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/19/2005 | CN1185228C Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain |
| 01/19/2005 | CN1185227C Novel compounds |
| 01/19/2005 | CN1185223C Novel Compounds and methods for synthesis and therapy |
| 01/19/2005 | CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/19/2005 | CN1185216C Fungicides |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/18/2005 | US6844446 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
| 01/18/2005 | US6844367 Benzamides and related inhibitors of factor Xa |
| 01/18/2005 | US6844357 Anticarcinogenic agents |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844344 Depression, anxiety; tobacco or nicotine withdrawal; such as 1-(benzofuran-4-yl)oxy-3-(4-(6-methoxybenzo(b)thiophen-2-yl)piperidinyl)-2 -propanol oxalate |
| 01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
| 01/18/2005 | CA2158458C Taxanes prepared by beta-lactams and ammonium alkoxides |
| 01/13/2005 | WO2005003131A1 Tricyclic delta opioid modulators |
| 01/13/2005 | WO2005003118A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 01/13/2005 | WO2005003115A1 Thiophene amino acid derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/13/2005 | WO2005003114A1 5-fluoro-thiopen-compounds,the process for their preparation,the pharmaceutical compositions containing them and their use as metallopotenases inhibitors |
| 01/13/2005 | WO2005003103A2 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases |
| 01/13/2005 | WO2005003102A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase |
| 01/13/2005 | WO2005003101A2 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 01/13/2005 | WO2005003099A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | WO2005003097A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | WO2005003089A2 7-ethynyl-2,4,9-trithiaadamantane and related methods |
| 01/13/2005 | WO2005002552A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 01/13/2005 | WO2005002514A2 Compounds having inhibitibe activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 01/13/2005 | WO2004106329A3 Novel antiinfective compounds and their pharmaceutical compositions |
| 01/13/2005 | WO2004099192A3 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
| 01/13/2005 | WO2004082623A3 Substituted piperidine compounds |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | WO2004050035A3 Benzimidazoles and analogs thereof as antivirals |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009876 Indazole compounds, compositions thereof and methods of treatment therewith |
| 01/13/2005 | US20050009870 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 01/13/2005 | US20050009864 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them |
| 01/13/2005 | US20050009860 Tricyclic delta-opioid modulators |
| 01/13/2005 | US20050009853 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 01/13/2005 | US20050009844 Inhibitors of p38 |
| 01/13/2005 | US20050009840 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 01/13/2005 | US20050009839 Novel azoles having an insecticidal action |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009829 1-Substituted 2-carboxamide derivatives of fused ring imidazoles, e.g., -[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-benzoimidazole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide |
| 01/13/2005 | US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 01/13/2005 | US20050009819 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/13/2005 | US20050009817 Substituted heteroaryls |
| 01/13/2005 | US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 01/13/2005 | US20050009804 N-heterocyclyl- or cycloalkyl-N-(2-carboxy-5-aryl-3-thiophenyl)cycloalkanecarboxamides, e.g., 5-(3-fluorophenyl)-3-[isopropyl-(4-methylcyclohexanecarbonyl)amino]-thiophene-2-carboxylic acid; especially for prevention and treatment of HVC |
| 01/13/2005 | US20050009755 (74)(3S)-3-amino-1-(1-benzyl-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-4-yl)-5-methyl-2-heptanone for example; cysteine protease inhibitors; treating bone resorption diseases such as osteoporosis |
| 01/13/2005 | US20050006246 Nitrogen atom transfer |
| 01/13/2005 | DE10328479A1 6-Arylamino-5-cyano-4-pyrimidinone 6-arylamino-5-cyano-4-pyrimidinones |
| 01/13/2005 | DE10328400A1 One-pot synthesis of carbocyclic or heterocyclic compounds, especially pyrimidine useful as components of natural products or drugs, from acid halide, alkyne and active hydrogen compound |
| 01/13/2005 | CA2531327A1 Compounds and therapeutical use thereof |
| 01/13/2005 | CA2531061A1 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | CA2531050A1 Pharmaceutical compounds |
| 01/13/2005 | CA2530816A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronic inflammatory diseases |
| 01/13/2005 | CA2530389A1 Pyrazine and pyridine derivatives as rho kinase inhibitors |
| 01/13/2005 | CA2528119A1 Cis-2,4,5-triaryl-imidazolines |
| 01/12/2005 | EP1495017A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 01/12/2005 | EP1495004A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands |
| 01/12/2005 | EP1495003A1 Fredericamycin derivatives |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/12/2005 | EP1495001A1 Antibacterial agents |
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494671A1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
| 01/12/2005 | EP1494668A2 Use of benzimidazole analogs in the treatment of cell proliferation |
| 01/12/2005 | EP1494663A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss |
| 01/12/2005 | EP1171423B1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands |